Target intelligence / Profile preview

Blood-borne toxin

Molecular classification
Other
01

Overview

The term **"blood-borne toxin"** is not recognized as a specific molecular target, receptor, enzyme, or protein. Instead, it is an imprecise and non-canonical phrase that generally refers to any toxic substance present in the bloodstream. In scientific and medical literature, the more accurate terms are **"bloodborne pathogen"** (referring to infectious microorganisms such as viruses and bacteria carried in blood that cause disease) or **specific toxins** (such as bacterial exotoxins like tetanus toxin). Bloodborne pathogens include hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), malaria parasites, syphilis-causing bacteria, among others[1][2][3][4][5]. However, none of these are referred to collectively as "blood-borne toxins," nor does this phrase denote a single molecule or therapeutic target. If you seek information on a particular pathogenic agent or toxic molecule found in blood—such as botulinum neurotoxin or diphtheria toxin—please specify the exact name for structured data extraction. **Summary:** The entry “blood-borne toxin” is incorrect for use as a canonical drug discovery/therapeutic target because it does not refer to any single defined molecule but rather an overly broad and ambiguous concept encompassing many unrelated substances[3][4].

Other names
Bloodborne toxinBlood-borne toxinBloodborne pathogen
02

Biological functions

Other
03

Disease associations

InfectionOther
04

Safety considerations

Not a specific molecular target; refers to a broad class of agentsAmbiguous terminology may lead to confusion in research or clinical settings

Beyond the preview

Go deeper on Blood-borne toxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood-borne toxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call